StockWatch
·
Biotechnology: Biological Products (No Diagnostic Substances)
Quarterly ResultJun 12, 2026, 04:22 PM

Black Titan Corp Reports H1 2026 Net Loss of $3.09M; Revenue Down 29.9%

AI Summary

Black Titan Corp announced its unaudited consolidated financial results for the six months ended January 31, 2026, reporting a net loss of $3.09 million on total revenues of $1.18 million, a 29.9% decrease year-over-year. The company's gross profit declined, and general and administrative expenses surged significantly. Despite the overall revenue decline, SaaS Subscription services revenue increased by 40.7%, and Total Annual Recurring Revenue grew to $857,152. The company also introduced a new "DAT+" digital asset treasury strategy.

Key Highlights

  • Reported a net loss of $3,092,512 for the six months ended January 31, 2026.
  • Total revenues decreased by 29.9% to $1,179,735 for H1 2026 from $1,682,879 in H1 2025.
  • Gross profit for H1 2026 was $315,656, down from $620,996 in H1 2025.
  • General and administrative expenses surged to $3,300,862 in H1 2026 from $295,470 in H1 2025.
  • SaaS Subscription services revenue increased by 40.7% to $299,970 in H1 2026.
  • Implementation services revenue decreased by 57.2% to $260,141 in H1 2026.
  • Total Annual Recurring Revenue (ARR) grew to $857,152 in H1 2026 from $692,870 in H1 2025.
  • Introduced a new "DAT+" strategy for active management of corporate digital asset treasury.